Literature DB >> 15328079

Antiplasmodial chalcones inhibit sorbitol-induced hemolysis of Plasmodium falciparum-infected erythrocytes.

Mei-Lin Go1, Mei Liu, Prapon Wilairat, Philip J Rosenthal, Kevin J Saliba, Kiaran Kirk.   

Abstract

A series of alkoxylated and hydroxylated chalcones previously reported to have antiplasmodial activities in vitro were investigated for their effects on the new permeation pathways induced by the malaria parasite in the host erythrocyte membrane. Of 21 compounds with good antiplasmodial activities (50% inhibitory concentrations [IC(50)s], < or = 20 microM), 8 members were found to inhibit sorbitol-induced lysis of parasitized erythrocytes to a significant extent (< or = 40% of control values) at a concentration (10 microM) that was close to their antiplasmodial IC(50)s. Qualitative structure-activity analysis suggested that activity was governed to a greater extent by a substitution on ring B than on ring A of the chalcone template. Most of the active compounds had methoxy or dimethoxy groups on ring B. Considerable variety was permitted on ring A in terms of the electron-donating or -withdrawing property. Lipophilicity did not appear to be an important determinant for activity. Although they are not exceptionally potent as inhibitors (lowest IC(50), 1.9 microM), the chalcones compare favorably with other more potent inhibitors in terms of their selective toxicities against plasmodia and their neutral character.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328079      PMCID: PMC514760          DOI: 10.1128/AAC.48.9.3241-3245.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Furosemide analogues as potent inhibitors of the new permeability pathways of Plasmodium falciparum-infected human erythrocytes.

Authors:  Henry M Staines; Belinda C Dee; Martin O'Brien; Hans-Jochen Lang; Heinrich Englert; Heather A Horner; J Clive Ellory; Kiaran Kirk
Journal:  Mol Biochem Parasitol       Date:  2004-02       Impact factor: 1.759

2.  Structure-activity relationships of antileishmanial and antimalarial chalcones.

Authors:  Mei Liu; Prapon Wilairat; Simon L Croft; Agnes Lay-Choo Tan; Mei-Lin Go
Journal:  Bioorg Med Chem       Date:  2003-07-03       Impact factor: 3.641

3.  Increased permeability of the malaria-infected erythrocyte to organic cations.

Authors:  H M Staines; C Rae; K Kirk
Journal:  Biochim Biophys Acta       Date:  2000-01-15

4.  On the mode of action of phlorizin as an antimalarial agent in in vitro cultures of Plasmodium falciparum.

Authors:  S Kutner; W V Breuer; H Ginsburg; Z I Cabantchik
Journal:  Biochem Pharmacol       Date:  1987-01-01       Impact factor: 5.858

5.  Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones.

Authors:  M Chen; L Zhai; S B Christensen; T G Theander; A Kharazmi
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

6.  Antimalarial alkoxylated and hydroxylated chalcones [corrected]: structure-activity relationship analysis.

Authors:  M Liu; P Wilairat; M L Go
Journal:  J Med Chem       Date:  2001-12-06       Impact factor: 7.446

7.  Characterization of permeation pathways appearing in the host membrane of Plasmodium falciparum infected red blood cells.

Authors:  H Ginsburg; S Kutner; M Krugliak; Z I Cabantchik
Journal:  Mol Biochem Parasitol       Date:  1985-03       Impact factor: 1.759

8.  Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity.

Authors:  J N Domínguez; J E Charris; G Lobo; N Gamboa de Domínguez; M M Moreno; F Riggione; E Sanchez; J Olson; P J Rosenthal
Journal:  Eur J Med Chem       Date:  2001-06       Impact factor: 6.514

9.  The antileishmanial activity of novel oxygenated chalcones and their mechanism of action.

Authors:  L Zhai; M Chen; J Blom; T G Theander; S B Christensen; A Kharazmi
Journal:  J Antimicrob Chemother       Date:  1999-06       Impact factor: 5.790

10.  Extracellular lysines on the plasmodial surface anion channel involved in Na+ exclusion.

Authors:  Jamieson V Cohn; Abdulnaser Alkhalil; Marissa A Wagner; Thavamani Rajapandi; Sanjay A Desai
Journal:  Mol Biochem Parasitol       Date:  2003-11       Impact factor: 1.759

View more
  10 in total

1.  Identification of novel phenyl butenonyl C-glycosides with ureidyl and sulfonamidyl moieties as antimalarial agents.

Authors:  K Kumar G Ramakrishna; Sarika Gunjan; Akhilesh Kumar Shukla; Venkata Reddy Pasam; Vishal M Balaramnavar; Abhisheak Sharma; Swati Jaiswal; Jawahar Lal; Renu Tripathi; Ravishankar Ramachandran; Rama Pati Tripathi
Journal:  ACS Med Chem Lett       Date:  2014-06-02       Impact factor: 4.345

2.  Maduramicin Rapidly Eliminates Malaria Parasites and Potentiates the Gametocytocidal Activity of the Pyrazoleamide PA21A050.

Authors:  Maxim I Maron; Crystal T Magle; Beata Czesny; Benjamin A Turturice; Ruili Huang; Wei Zheng; Akhil B Vaidya; Kim C Williamson
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

3.  Enone- and chalcone-chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in vitro metabolism, and mechanistic studies.

Authors:  Eric M Guantai; Kanyile Ncokazi; Timothy J Egan; Jiri Gut; Philip J Rosenthal; Ravi Bhampidipati; Anitha Kopinathan; Peter J Smith; Kelly Chibale
Journal:  J Med Chem       Date:  2011-05-05       Impact factor: 7.446

4.  Potent Plasmodium falciparum gametocytocidal activity of diaminonaphthoquinones, lead antimalarial chemotypes identified in an antimalarial compound screen.

Authors:  Takeshi Q Tanaka; W Armand Guiguemde; David S Barnett; Maxim I Maron; Jaeki Min; Michele C Connelly; Praveen Kumar Suryadevara; R Kiplin Guy; Kim C Williamson
Journal:  Antimicrob Agents Chemother       Date:  2014-12-15       Impact factor: 5.191

5.  Multifunctional nanoparticles for prostate cancer therapy.

Authors:  Shantanu S Chandratre; Alekha K Dash
Journal:  AAPS PharmSciTech       Date:  2014-09-05       Impact factor: 3.246

6.  Identification of inhibitors that dually target the new permeability pathway and dihydroorotate dehydrogenase in the blood stage of Plasmodium falciparum.

Authors:  Benjamin K Dickerman; Brendan Elsworth; Simon A Cobbold; Catherine Q Nie; Malcolm J McConville; Brendan S Crabb; Paul R Gilson
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

7.  The effects of trans-chalcone and chalcone 4 hydrate on the growth of Babesia and Theileria.

Authors:  Gaber El-Saber Batiha; Amany Magdy Beshbishy; Dickson Stuart Tayebwa; Oluyomi Stephen Adeyemi; Hazem Shaheen; Naoaki Yokoyama; Ikuo Igarashi
Journal:  PLoS Negl Trop Dis       Date:  2019-05-24

8.  In vitro anti-malarial efficacy of chalcones: cytotoxicity profile, mechanism of action and their effect on erythrocytes.

Authors:  Shweta Sinha; Daniela I Batovska; Bikash Medhi; B D Radotra; Ashish Bhalla; Nadezhda Markova; Rakesh Sehgal
Journal:  Malar J       Date:  2019-12-16       Impact factor: 2.979

9.  Cajachalcone: An Antimalarial Compound from Cajanus cajan Leaf Extract.

Authors:  E O Ajaiyeoba; O O Ogbole; O O Abiodun; J S Ashidi; P J Houghton; C W Wright
Journal:  J Parasitol Res       Date:  2013-07-18

Review 10.  An Update on Development of Small-Molecule Plasmodial Kinase Inhibitors.

Authors:  Chantalle Moolman; Rencia van der Sluis; Richard M Beteck; Lesetja J Legoabe
Journal:  Molecules       Date:  2020-11-07       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.